GlassScriptPhysician profile
Nordeli Estronza
NPI 1750333167
$483.21
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $22.61 · 2022: $133.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $132.63 | 2022 | |
| Alexion Pharmaceuticals, INC. | $55.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.65 | 2019 | |
| Lundbeck LLC | $31.13 | 2019 | |
| Genzyme Corporation | $24.92 | 2019 | |
| Csl Behring | $22.81 | 2019 | |
| Amgen INC. | $22.61 | 2020 | |
| Amneal Pharmaceuticals LLC | $22.31 | 2019 | |
| Neurocrine Biosciences, INC. | $20.07 | 2019 | |
| Avanir Pharmaceuticals, INC. | $19.79 | 2019 | |
| Grifols USA, LLC | $18.82 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.11 | 2019 | |
| Lilly USA, LLC | $15.56 | 2019 | |
| Bausch Health US, LLC | $14.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.32 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nordeli Estronza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.